NasdaqCM - Delayed Quote • USD
Evogene Ltd. (EVGN)
At close: April 25 at 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-21,577.0000
-21,577.0000
-23,678.0000
-24,716.0000
-19,514.0000
Investing Cash Flow
-4,538.0000
-4,538.0000
13,274.0000
-20,566.0000
9,415.0000
Financing Cash Flow
18,152.0000
18,152.0000
9,343.0000
30,276.0000
20,374.0000
End Cash Position
20,772.0000
20,772.0000
28,980.0000
32,325.0000
46,229.0000
Capital Expenditure
-785.0000
-785.0000
-1,171.0000
-847.0000
-682.0000
Issuance of Capital Stock
8,449.0000
8,449.0000
21.0000
29,582.0000
18,658.0000
Issuance of Debt
--
--
10,000.0000
--
--
Repayment of Debt
-836.0000
-836.0000
-803.0000
-580.0000
-639.0000
Free Cash Flow
-22,362.0000
-22,362.0000
-24,849.0000
-25,563.0000
-20,196.0000
12/31/2020 - 10/15/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CGEN Compugen Ltd.
1.9000
-0.52%
ENLV Enlivex Therapeutics Ltd.
1.4500
-3.33%
CANF Can-Fite BioPharma Ltd.
1.9200
-1.03%
PLUR Pluri Inc.
4.9000
-3.73%
BLRX BioLineRx Ltd.
0.5753
-6.15%
XTLB XTL Biopharmaceuticals Ltd.
2.4000
-6.25%
ORMP Oramed Pharmaceuticals Inc.
2.3000
-2.95%
PSTX Poseida Therapeutics, Inc.
2.0500
-0.97%
PPBT Purple Biotech Ltd
0.5160
-0.96%
PRTG Portage Biotech Inc.
0.2370
-9.78%